Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases.
about
Treatment of Cushing disease: overview and recent findingsDifferential localization of flavin-containing monooxygenase (FMO) isoforms 1, 3, and 4 in rat liver and kidney and evidence for expression of FMO4 in mouse, rat, and human liver and kidney microsomesSkin conditions in the athlete.Enantiospecific effects of ketoconazole on aryl hydrocarbon receptor.An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.Onychomycosis. New therapies for an old diseasePharmacological management of Cushing's syndrome: an update.Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.Looking beyond highly active antiretroviral therapy: drug-related hepatotoxicity in patients with human immunodeficiency virus infection.A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs.Drug-Induced Liver Injury: Pattern Recognition and Future Directions.Onychomycosis. Going for cureA survey of clinical practice patterns in diagnosis and management of Cushing's disease in Iran.Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents.Comparative Hepatotoxicity of Fluconazole, Ketoconazole, Itraconazole, Terbinafine, and Griseofulvin in Rats.Oral therapy for onychomycosis: an evidence-based review.Liver injury associated with ketoconazole: review of the published evidence.Drug safety assessment of oral formulations of ketoconazole.The Rise and Fall of Oral Ketoconazole.Antifungal agents and liver toxicity: a complex interaction.Current issues in onychomycosis.Hepatotoxicity related to itraconazole: report of three cases.Ketoconazole treatment in Cushing's syndrome: experience in 34 patients.Corticotropin-dependent Cushing's syndrome in older people: presentation of five cases and therapeutical use of ketoconazole.Hepatocellular Toxicity of Imidazole and Triazole Antimycotic Agents.
P2860
Q24626819-BB13F668-C9B5-4304-870A-E3ABF2BA7EF1Q28567676-6BD00B84-A1A2-4A50-9C6D-D6A106321B4DQ33383128-31F601A0-D491-479B-8A48-91F93EF4B2DBQ33856001-B0A9D901-06F2-4A77-B2F7-C75999D4C497Q34004690-2AD7B974-8372-4B86-B499-05C0BB1EEC49Q34184524-7C4437A1-EF19-4ADC-A8D7-5B5B6DC878ECQ34587379-7B9D1A49-7958-40D6-897E-74A9F6920207Q34980027-BBA0FF87-E89A-47E0-8D45-D396316083D1Q34998102-911E4D17-44E6-41FC-9DA5-4D0AA0DC312FQ36053665-570FC08D-67FD-460E-A63F-AC4DF3B34715Q36412863-DC7849F5-09BD-4F14-914A-4FFFC9CBFF0EQ36479370-108BC838-1EFD-4D68-A991-68AC99467CEBQ36983219-AAA64CBA-70B2-4A76-A826-CBC8E7A74818Q37157893-E2603A23-29E3-40E8-9506-35F39571B889Q37651540-15A89624-71D7-4A38-B035-B35A62F5B9D6Q38172442-BEADC4E8-568E-4174-9D23-C896771FCB95Q38248677-73CD4E95-326E-426B-9EB6-6421E54D3AF1Q38269550-1C57CCCB-FE83-46F9-BEAC-3F21BB8F6AB4Q38379848-38698252-8C14-4924-AEE5-FE0B33A9550DQ38858839-C48897B9-B3F1-4396-80A7-FFA9A896A187Q41718745-5C0381AE-7856-41E2-A3A7-F012082C6BF5Q43907395-B2C9A5CE-591B-4013-A301-7723AFEAE143Q44256228-36796861-6C92-4C88-A499-4F6F893F0807Q47817508-9E4E00C5-86AF-45FA-8A4F-820CA467ABB2Q52698203-476455E6-052D-4DE1-BE45-E619D9D3053C
P2860
Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases.
@en
type
label
Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases.
@en
prefLabel
Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases.
@en
P2093
P1476
Ketoconazole-associated hepatic injury. A clinicopathological study of 55 cases.
@en
P2093
B H Stricker
F B Bronkhorst
G E Van Parys
V J Desmet
P304
P356
10.1016/S0168-8278(86)80495-0
P577
1986-01-01T00:00:00Z